Janux Therapeutics, Inc. · NASDAQ:JANX
Dobek Maria sold 2,038 Janux Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Dobek Maria (Vice President, Accounting) sold 2,038 Janux Therapeutics, Inc. shares at US$14.17 for US$28,878, leaving 32,270 shares. Filed May 13, 2026 (Form 4).
- Sold
- 2,038 shares
- Price
- US$14.17
- Value
- US$28,878
- Holding after
- 32,270 shares
- Trading plan
- No
- Role
- Vice President, Accounting
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 2,038 | US$14.17 | 32,270 | Direct |
Source
Related
- Janux Therapeutics, Inc.
- Dobek Maria
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026